• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎患者中非酒精性脂肪性肝病的患病率:一项荟萃分析。

Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis.

作者信息

Zhang Li, Wu Hong-Di, Qian Yuan-Fang, Xu Hong-Yan

机构信息

Department of Infectious Diseases, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.

Department of Nursing, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.

出版信息

World J Clin Cases. 2024 Sep 6;12(25):5749-5760. doi: 10.12998/wjcc.v12.i25.5749.

DOI:10.12998/wjcc.v12.i25.5749
PMID:39247728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11263053/
Abstract

BACKGROUND

The prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with chronic hepatitis B (CHB) has increased in recent clinical practice; however, the relationship between CHB and hepatic steatosis (HS) remains controversial.

AIM

To shed light on the potential association between NAFLD and hepatitis B virus (HBV) infection.

METHODS

We conducted a systematic literature search using multiple databases, including PubMed, the Cochrane Library, Web of Science, and EMBASE, to identify relevant studies. Predefined inclusion criteria were used to determine the eligibility of the studies for further analysis.

RESULTS

Comprehensive meta-analysis software was used for statistical analysis, which covered 20 studies. The results indicated a lower NAFLD susceptibility in HBV-infected individuals (pooled OR = 0.87; 95%CI = 0.69-1.08; = 91.1%), with diabetes ( = 0.015), body mass index (BMI; = 0.010), and possibly age ( = 0.061) as heterogeneity sources. Of note, in four studies (6197 HBV patients), HBV-infected individuals had a reduced NAFLD risk (OR = 0.68, 95%CI = 0.51-0.89, = 0.006). A positive link between hyperlipidemia and metabolic syndrome emerged in hepatitis B patients, along with specific biochemical indicators, including BMI, creatinine, uric acid, fasting blood glucose, and homeostasis model assessment of insulin resistance.

CONCLUSION

HBV infection may provide protection against HS; however, the occurrence of HS in patients with HBV infection is associated with metabolic syndrome and specific biochemical parameters.

摘要

背景

在最近的临床实践中,慢性乙型肝炎(CHB)患者中非酒精性脂肪性肝病(NAFLD)的患病率有所增加;然而,CHB与肝脂肪变性(HS)之间的关系仍存在争议。

目的

阐明NAFLD与乙型肝炎病毒(HBV)感染之间的潜在关联。

方法

我们使用多个数据库进行了系统的文献检索,包括PubMed、Cochrane图书馆、Web of Science和EMBASE,以识别相关研究。使用预定义的纳入标准来确定研究是否符合进一步分析的条件。

结果

使用综合荟萃分析软件进行统计分析,共纳入20项研究。结果表明,HBV感染个体的NAFLD易感性较低(合并OR = 0.87;95%CI = 0.69 - 1.08;I² = 91.1%),异质性来源包括糖尿病(I² = 0.015)、体重指数(BMI;I² = 0.010),可能还有年龄(I² = 0.061)。值得注意的是,在四项研究(6197例HBV患者)中,HBV感染个体的NAFLD风险降低(OR = 0.68,95%CI = 0.51 - 0.89,P = 0.006)。在乙型肝炎患者中,高脂血症与代谢综合征之间出现了正相关,同时还与特定的生化指标相关,包括BMI、肌酐、尿酸、空腹血糖和胰岛素抵抗的稳态模型评估。

结论

HBV感染可能对HS具有保护作用;然而,HBV感染患者中HS的发生与代谢综合征和特定的生化参数有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/766c68337c42/WJCC-12-5749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/8a45ea2103bf/WJCC-12-5749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/ed91a839e4ad/WJCC-12-5749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/766c68337c42/WJCC-12-5749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/8a45ea2103bf/WJCC-12-5749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/ed91a839e4ad/WJCC-12-5749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ba/11263053/766c68337c42/WJCC-12-5749-g003.jpg

相似文献

1
Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis.乙型肝炎患者中非酒精性脂肪性肝病的患病率:一项荟萃分析。
World J Clin Cases. 2024 Sep 6;12(25):5749-5760. doi: 10.12998/wjcc.v12.i25.5749.
2
Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis.乙型肝炎病毒感染合并非酒精性脂肪性肝病:相互作用与预后
Heliyon. 2023 Jan 20;9(1):e13113. doi: 10.1016/j.heliyon.2023.e13113. eCollection 2023 Jan.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis.乙型肝炎病毒感染与非酒精性脂肪性肝病风险:一项荟萃分析。
Oncotarget. 2017 Nov 3;8(63):107295-107302. doi: 10.18632/oncotarget.22364. eCollection 2017 Dec 5.
5
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.肝脂肪变性和 2 型糖尿病的发展:慢性乙型肝炎和病毒特异性因素的影响。
J Formos Med Assoc. 2022 Aug;121(8):1478-1487. doi: 10.1016/j.jfma.2021.10.014. Epub 2021 Nov 8.
6
Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review.代谢综合征、非酒精性脂肪性肝病与慢性乙型肝炎:一项叙述性综述
Infect Dis Ther. 2023 Jan;12(1):53-66. doi: 10.1007/s40121-022-00725-6. Epub 2022 Nov 27.
7
Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.连锁的PNPLA3基因多态性赋予非酒精性脂肪性肝炎易感性,并降低慢性乙型肝炎的病毒载量。
World J Gastroenterol. 2015 Jul 28;21(28):8605-14. doi: 10.3748/wjg.v21.i28.8605.
8
Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis.非酒精性脂肪性肝病对慢性乙型肝炎患者抗病毒治疗反应的影响:一项荟萃分析。
World J Hepatol. 2024 Mar 27;16(3):465-476. doi: 10.4254/wjh.v16.i3.465.
9
A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B.非酒精性脂肪性肝病如何影响e抗原阳性慢性乙型肝炎患者抗病毒治疗的Meta分析
Emerg Med Int. 2022 Oct 3;2022:4774195. doi: 10.1155/2022/4774195. eCollection 2022.
10
Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis.肝脂肪变性对慢性乙型肝炎患者的并发情况及影响:一项系统评价和荟萃分析
Ann Transl Med. 2021 Dec;9(23):1718. doi: 10.21037/atm-21-3052.

本文引用的文献

1
Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B.慢性乙型肝炎患者群体中总胆固醇与高密度脂蛋白比值和非酒精性脂肪性肝病的关系
World J Hepatol. 2022 Apr 27;14(4):791-801. doi: 10.4254/wjh.v14.i4.791.
2
A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease.慢性乙型肝炎病毒感染合并非酒精性脂肪性肝病患者中一种新型的HBV相关炎症无创诊断模型
Front Med (Lausanne). 2022 Mar 23;9:862879. doi: 10.3389/fmed.2022.862879. eCollection 2022.
3
Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
非酒精性脂肪性肝病对亚洲慢性乙型肝炎患者结局的影响。
Liver Int. 2022 Aug;42(9):1981-1990. doi: 10.1111/liv.15252. Epub 2022 Jul 7.
4
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.脂肪肝进展算法和脂肪变性、活动度及纤维化评分在评估非酒精性脂肪肝对未经治疗的慢性乙型肝炎患者影响中的应用。
Front Cell Infect Microbiol. 2022 Jan 17;11:733348. doi: 10.3389/fcimb.2021.733348. eCollection 2021.
5
Association of metabolic dysfunction-associated fatty liver disease with kidney disease.代谢功能障碍相关脂肪性肝病与肾脏疾病的关联
Nat Rev Nephrol. 2022 Apr;18(4):259-268. doi: 10.1038/s41581-021-00519-y. Epub 2022 Jan 10.
6
Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B.水飞蓟宾胶囊联合生活方式改变对慢性乙型肝炎患者肝脂肪变性的影响。
Sci Rep. 2021 Jan 12;11(1):655. doi: 10.1038/s41598-020-80709-z.
7
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.ABIDE:一种用于预测非酒精性脂肪性肝病相关肝硬化患者肝失代偿的准确模型。
Hepatology. 2021 Jun;73(6):2238-2250. doi: 10.1002/hep.31576. Epub 2021 Apr 19.
8
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan.台湾非酒精性脂肪性肝病患者的病理发现及合并乙型肝炎病毒感染的影响。
J Formos Med Assoc. 2020 Oct;119(10):1476-1482. doi: 10.1016/j.jfma.2020.05.027. Epub 2020 Jun 1.
9
HBV-Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCC.HBV 诱导的 PTEN RNA N6 甲基腺苷修饰增加影响固有免疫并促进 HCC。
Hepatology. 2021 Feb;73(2):533-547. doi: 10.1002/hep.31313. Epub 2020 Nov 7.
10
Epidemiology of non-alcoholic fatty liver disease in Asia.亚洲非酒精性脂肪性肝病的流行病学
Indian J Gastroenterol. 2020 Feb;39(1):1-8. doi: 10.1007/s12664-020-01018-x. Epub 2020 Mar 9.